Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Elixir Department: SOP for Verification of Test Results – V 2.0

Posted on By

Elixir Department: SOP for Verification of Test Results – V 2.0

Standard Operating Procedure for Verification of Test Results in Elixir Quality Control

Department Elixir Department
SOP No. SOP/ELX/237/2025
Supersedes SOP/ELX/237/2022
Page No. Page 1 of 7
Issue Date 11/04/2025
Effective Date 15/04/2025
Review Date 11/04/2026

1. Purpose

To define the procedure for the systematic verification of test results obtained during the quality control testing of elixir formulations to ensure data accuracy, reliability, and regulatory compliance.

2. Scope

This SOP applies to all raw data, calculations, instrument printouts, and final reports generated by the QC Department during in-process, finished product, and stability testing of elixirs.

3. Responsibilities

  • QC Analyst:
    • Record raw data legibly and accurately, ensuring calculations are complete and traceable.
  • QC Reviewer/Supervisor:
    • Verify calculations, instrument results, and compliance with specifications.
  • QA Officer:
    • Perform final verification prior to release of data and ensure traceability in audit trails.
See also  Elixir Department: SOP for Intermediate Holding Studies - V 2.0

4. Accountability

The QC Head is accountable for implementation and adherence to this SOP. The QA Head is responsible for ensuring integrity and regulatory acceptance of verified data.

5. Procedure

5.1 Data Entry by Analyst

  1. All results must be entered in black ink without overwriting or use of correction fluid.
  2. Any correction shall be signed, dated, and the reason mentioned.
  3. Results must be entered in predefined formats or test datasheets.
  4. Ensure calculations are done using approved methods and formulas.

5.2 Initial Review by Supervisor

  1. Verify:
    • Sample ID and batch number consistency
    • Instrument calibration status
    • Use of correct analytical method and version
    • Units, decimal accuracy, and limit compliance
  2. Cross-check all manual calculations or those from spreadsheets.
  3. Review chromatograms, spectrums, or graphs for anomalies or integration errors.

5.3 Second-Level QA Verification

  1. Confirm that:
    • All results fall within approved specifications
    • No test has been repeated without justification
    • Out-of-trend or OOS results are properly documented and investigated
    • Analyst and reviewer signatures are present on all pages
  2. QA to stamp and sign the final report for approval and archival.
See also  Elixir Department: SOP for Calibration of Dispensing Balances - V 2.0

5.4 Handling of Errors or Deviations

  1. If discrepancies are identified:
    • Document under test discrepancy record
    • Initiate a deviation or OOS as per applicable SOP
    • Perform root cause analysis if necessary
  2. Re-testing shall be permitted only after QA approval and documented justification.

5.5 Final Report Compilation

  1. Ensure all raw data, printouts, calibration records, and calculations are compiled chronologically.
  2. Label each page with sample ID, batch number, and analyst initials.
  3. Final report shall be approved and archived in the product data file (PDF).

6. Abbreviations

  • SOP: Standard Operating Procedure
  • QC: Quality Control
  • QA: Quality Assurance
  • OOS: Out of Specification
  • PDF: Product Data File
See also  Elixir Department: SOP for Operation of Filter Press - V 2.0

7. Documents

  1. Test Result Verification Logbook (Annexure-1)
  2. Batch Manufacturing Record (BMR)
  3. Test Datasheets and Raw Data Sheets

8. References

  • 21 CFR Part 211.194 – Laboratory Records
  • WHO TRS 986 Annex 2 – Good Practices for QC Laboratories
  • ICH Q7 – Good Manufacturing Practice Guide

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Test Result Verification Logbook

Date Batch No. Test Parameter Analyst Verified By Comments/Corrections
11/04/2025 ELX-0425-053 Assay Rajesh Kumar Sunita Reddy None

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 1.0 Initial SOP Release New SOP Creation QA Head
11/04/2025 2.0 Included second-level QA verification process GMP Compliance Update QA Head
Elixers V 2.0 Tags:Elixir colorants, Elixir dosage form, Elixir filtration techniques, Elixir flavoring agents, Elixir formulation, Elixir GMP compliance, Elixir manufacturing process, Elixir manufacturing SOPs, Elixir packaging requirements, Elixir pharmacopoeial standards, Elixir preparation methods, Elixir preservatives, Elixir production equipment, Elixir quality control, Elixir regulatory guidelines, Elixir shelf life, Elixir stability testing, Elixir sterilization methods, Elixir storage conditions, Elixir sweetening agents, Elixir viscosity modifiers, Hydroalcoholic solutions, Medicated elixirs, Non-medicated elixirs, Pharmaceutical elixirs

Post navigation

Previous Post: Analytical Method Development: SOP for System Performance Qualification of FTIR Spectrophotometer – V 2.0
Next Post: Analytical Method Development: SOP for Management of Stability-Indicating Method Validation – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version